Technical Analysis for TNDM - Tandem Diabetes Care, Inc.

Grade Last Price % Change Price Change
grade B 88.05 -2.10% -1.89
TNDM closed down 2.1 percent on Friday, February 21, 2020, on 85 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Feb 24
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical TNDM trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Slingshot Bullish Bullish Swing Setup -2.10%
New 52 Week High Strength -2.10%
Upper Bollinger Band Walk Strength -2.10%
Multiple of Ten Bearish Other -2.10%
Outside Day Range Expansion -2.10%
Wide Bands Range Expansion -2.10%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Tandem Diabetes Care, Inc., a medical device company, focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes. The company's products include t:slim Insulin Delivery System that comprises t:slim pump, its disposable cartridge, and an infusion set; and t:connect Diabetes Management Application, a PC and Mac-compatible, cloud-based data management application that provides users, their caregivers, and their healthcare providers a fast, easy, and visual way to display therapy management data from the pump and supported blood glucose meters. It sells its products in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.
Medicine Diabetes Healthcare Providers Endocrine System Diabetes Mellitus Insulin Endocrinology Diabetes Care Insulin Delivery Diabetes Management Diabetes Mellitus Type 1 Insulin Dependent Diabetes

Is TNDM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 91.65
52 Week Low 47.36
Average Volume 1,520,922
200-Day Moving Average 65.25
50-Day Moving Average 69.38
20-Day Moving Average 78.74
10-Day Moving Average 84.06
Average True Range 3.36
ADX 58.57
+DI 37.98
-DI 4.48
Chandelier Exit (Long, 3 ATRs ) 81.57
Chandelier Exit (Short, 3 ATRs ) 76.21
Upper Bollinger Band 92.20
Lower Bollinger Band 65.27
Percent B (%b) 0.85
BandWidth 34.21
MACD Line 5.65
MACD Signal Line 4.66
MACD Histogram 0.9875
Fundamentals Value
Market Cap 442.32 Million
Num Shares 5.02 Million
EPS -25.15
Price-to-Earnings (P/E) Ratio -3.50
Price-to-Sales 0.17
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 93.03
Resistance 3 (R3) 93.17 91.65 92.20
Resistance 2 (R2) 91.65 90.38 91.58 91.92
Resistance 1 (R1) 89.85 89.60 89.09 89.71 91.65
Pivot Point 88.33 88.33 87.95 88.26 88.33
Support 1 (S1) 86.53 87.06 85.77 86.39 84.45
Support 2 (S2) 85.01 86.28 84.94 84.18
Support 3 (S3) 83.21 85.01 83.90
Support 4 (S4) 83.07